TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

The Motley Fool Logo The Motley Fool • •By Cory Renauer
Harel Bets Big on Teva Pharmaceutical by Purchasing 4.3 Million Shares

Harel Insurance Investments & Financial Services Ltd. significantly increased its stake in Teva Pharmaceutical by purchasing 4.3 million shares, valued at approximately $75.64 million, making Teva its largest holding at 6.84% of its U.S. equity assets.

Insights
MSpF   neutral

Analyst Kristine Liwag maintained a hold recommendation with a reduced price target of $45


TEVA   neutral

The company shows modest revenue growth (expected 3% year-over-year) and potential earnings improvement from branded drug sales, but has negative net income in the trailing twelve months